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Available online 23 August 2012Abstract Ascorbic acid (Vitamin C) has a critical role in bone formation and osteoblast differentiation, but very little is
known about the molecular mechanisms of ascorbic acid entry into bone marrow stromal cells (BMSCs). To address this gap in
knowledge, we investigated the identity of the transport system that is responsible for the uptake of ascorbic acid into bone
marrow stromal cells (BMSCs). First, we examined the expression of the two known isoforms of the sodium-coupled ascorbic
acid transporter, namely SVCT1 and SVCT2, in BMSCs (Lin−ve Sca1+ve) and bone at the mRNA level. Only SVCT2 mRNA was
detected in BMSCs and bone. Uptake of ascorbic acid in BMSCs was Na+-dependent and saturable. In order to define the role of
SVCT2 in BMSC differentiation into osteoblasts, BMSCs were stimulated with osteogenic media for different time intervals, and
the activity of SVCT2 was monitored by ascorbic acid uptake. SVCT2 expression was up-regulated during the osteogenic
differentiation of BMSCs; the expression was maximal at the earliest phase of differentiation. Subsequently, osteogenesis was
inhibited in BMSCs upon knock-down of SVCT2 by lentivirus shRNA. We also found that the expression of the SVCT2 could be
negatively or positively modulated by the presence of oxidant (Sin-1) or antioxidant (Ascorbic acid) compounds, respectively,
in BMSCs. Furthermore, we found that this transporter is also regulated with age in mouse bone. These data show that SVCT2
plays a vital role in the osteogenic differentiation of BMSCs and that its expression is altered under conditions associated with
redox reaction. Our findings could be relevant to bone tissue engineering and bone related diseases such as osteoporosis in
which oxidative stress and aging plays important role.
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5613.
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37Expression and function of SVCT2 in bone marrow stromal cells and in osteogenesisIntroduction Isolation of BMSCs from miceAscorbic acid (AA; vitamin C) is a water-soluble vitamin and the
primary antioxidant with ability to scavenge reactive oxygen
and nitrogen species (Levine et al., 1999; Conner and Grisham,
1996). It decreases oxidative stress associated with the
bone-resorptive process and might help in the prevention of
osteoporosis (Basu et al., 2001; Ruiz-Ramos et al., 2010).
Ascorbic acid is also an essential cofactor for prolyl hydroxylase
(Togari et al., 1995) and in-vitro differentiation of osteoblasts
and other mesenchymal-derived cells (Franceschi, 1992). The
bone matrix contains over 90% of protein as collagen (Termine,
1990) and it is well known that ascorbic acid is an essential
cofactor for collagen synthesis and maturation (Peterkofsky,
1991). Animal studies have demonstrated that deficiency of this
vitamin leads to impaired bone mass, cartilage, and connective
tissue (Poal-Manresa et al., 1970; Kipp et al., 1996; Miyajima et
al., 1995). In addition to its involvement in collagen synthesis,
ascorbic acid has also been reported to be necessary for the
proliferation and multilayering of osteoblastic cells (Bellows et
al., 1986). Being highly water-soluble, ascorbic acid cannot
permeate the hydrophobic plasmamembrane of cells and hence
requires a specific transport process to enter into mammalian
cells. The entry of ascorbic acid into mammalian cells is
mediated by a Na+-dependent transport system (Wilson and
Dixon, 1989; Franceschi et al., 1995). This is an active process
and it enables cells to concentrate ascorbic acid against a
concentration gradient. Most of the studies in literature related
to ascorbic acid and bone metabolism have been carried out
using themurine osteoblastic-like cell line MC3T3-E1. MC3T3-E1
cells are the pre-osteoblastic and are commonly employed for
studies of osteoblast differentiation (Schindeler et al., 2010). In
contrast, bone marrow stromal cells (BMSCs) are progenitor
cells which differentiate into osteoblasts, osteocytes, adipo-
cytes, and cartilage (Prockop, 1997; Pittenger et al., 1999).
BMSCs can be harvested from bone marrow, expanded in
culture, and induced to differentiate. Ascorbic acid and
collagen synthesis are important aspects of BMSC differentia-
tion and bone formation (Miyajima et al., 1995). However, little
is known about the molecular aspects of the transport process
that is responsible for active accumulation of ascorbic acid in
these pluripotent stem cells.
The purpose of this investigation was to provide the first
detailed analysis of the ascorbic acid uptake process in mouse
primary BMSCs as well as its regulation during osteogenesis and
oxidative stress. To this end, we isolated lineage-negative
Sca1-positive BMSCs and used them for the characterization of
the ascorbic acid transport process at the functional and
molecular levels in undifferentiated state and during their
differentiation into osteoblasts. In addition, we induced
oxidative stress in cell culture system using Sin-1 and performed
uptake assay to investigate SVCT2 regulation and protective
effect of ascorbic acid on BMSCs.Material and methods
Animals
This study was approved by the Institutional Animal Care and
Use Committee of the Georgia Health Science University.Murine BMSCs were isolated from the long bones of
6 month-old C57BL/6 mice (n=6). The mice were euthanized
and the femurs and humeri removed. The marrow was then
flushed with phosphate-buffered saline (PBS) and the
cellular material harvested. The cellular material was then
centrifuged, the supernatant discarded and the pellet washed
with PBS. The cells were then plated in 100-cm2 culture plates
with DMEM, supplemented with 10% heat-inactivated fetal
bovine serum (FBS), 50 U/mL penicillin/streptomycin, and
2 mM L-glutamine. After 24 h, the supernatant were removed
and the adherent stromal cells trypsinized for negative
selection. A negative selection process was used to deplete
hematopoietic cell lineages (T- and B-lymphocytic, myeloid
and erythroid cells) using a commercially available kit (BD
biosciences), thus retaining the progenitor (stem) cell popu-
lation. The positive fractions were collected using the
following parameters: negative for CD3e (CD3 ε chain),
CD11b (integrin αM chain), CD45R/B220, Ly-6G and Ly-6C
(Gr-1), and TER-119/Erythroid Cells (Ly-76). Next, positive
selections were performed using the anti-Stem cell antigen-1
(Sca-1) column magnetic bead sorting kit (Miltenyi Biotec,).Isolation of RNA, synthesis of cDNA, and real-time PCR
Total RNA was isolated from long bone (femur), calvaria,
BMSCs and liver of mice. For aging studies, 12 month (n=5)
and 24 month (n=5) mice were sacrificed and femora were
excised. The epiphyses of the femur were removed and the
marrow was flushed out with PBS. The diaphyses were then
snap-frozen in liquid nitrogen. In the case of femur, calvaria,
and liver, the tissue was ground in liquid N2 with a pestle and
mortar, and the powdered tissue was dissolved in Trizol for
RNA isolation. For BMSCs, cell pellet was directly dissolved in
trizol. RNA was isolated using the Trizol method following
manufacturer's instructions, and the quality of the RNA
preparations was monitored by absorbance at 260 and 280 nm
(Helios-Gamma, Thermo Spectronic, Rochester, NY). The RNA
was reverse-transcribed into complementary deoxyribonucleic
acid (cDNA) using iScript reagents from Bio-Rad on a program-
mable thermal cycler (PCR-Sprint, Thermo Electron, Milford,
MA). 50 ng of cDNA was amplified in each real-time PCR using
a Bio-Rad iCycler, ABgene reagents (Fisher scientific) using
appropriate primers (Table 1). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as the internal control for
normalization.Immunocytochemical analysis of SVCT2 expression
in mice BMSCs
The mouse BMSCs (Lin−ve Sca-1+) cells were grown on
multi-chamber slide for 24 h and then fixed in ice-cold 4%
paraformaldehyde for immunostaining. The slides were
stained with goat anti-SVCT-2 polyclonal antibody (1:50
dilution) (Santa Cruz) followed by FITC-labeled anti-goat IgG
as the secondary antibody (1:200) (Sigma-Aldrich). The
slides were counterstained with Hoechst dye to label nuclei
and then mounted in aqueous medium.
Table 1 Nucleotide sequences of mouse primers used for RT-PCR.
Gene Primer Product size
in base pair
Annealing temperature
(°C)
Reference/accession
number
GAPDH CAT GGC CTC CAA GGA GTA AGA 105 60 M32599
GAG GGA GAT GCT CAG TGT TGG
SVCT1 GGC ATC ATT GAG TCC ATC GG 117 60 Kuo et al., 2004
ATA GCC CCG CGA TGA TGC AG
SVCT2 TAA TCC TGG CTA TCC TCG TG 105 60 Kuo et al., 2004
CAT CTG TGC GTG CAT AGT AGC
Collagen type I GCC CAT TAG CCG GTA TGT TAT TA 112 60 U50767.1
TCC CTG GTA CCT ATG GAG ACT GT
BMP-2 TGT TTG GCC TGA AGC AGA GA 83 60 NM_007553.2
TGA GTG CCT GCG GTA CAG AT
RUNX-2 GGA AAG GCA CTG ACT GAC CTA 103 60 NM_009820
ACA AAT TCT AAG CTT GGG AGG A
Osteocalcin ATT TAG GAC CTG TGC TGC CCT A 120 60 U11542.1
GGA GCT GCT GTG ACA TCC ATA C
38 S. Fulzele et al.Uptake studies
BMSCs were seeded in 24-well plates at an initial density of
0.01×106 cells/well. Uptake of [14C] ascorbic acid was
measured on 3rd day post-seeding. The medium was removed
by aspiration and the cells washed with uptake buffer once.
Uptake was initiated by adding 0.25 mL of uptake buffer
containing [14C] ascorbic acid (20 nM). Initial experiments
were carried out to determine the time course of uptake.Figure 1 RT-PCR showing the absence of SVCT1 and presence o
and other experimental details for RT-PCR are provided in Materia
Lane 3: Mouse cavaria Lane 4: Positive control (Mouse liver).
(b) Immunohistochemical localization of SVCT2 protein in mice b
protein in mice BMSCs. The immunofluorescence analysis was perfo
antibody was anti-rabbit IgG labeled with FITC. The nuclei were stSubsequent uptake measurements were made with 15 min
incubation representing initial uptake rates. Uptake was
terminated by aspiration of the uptake buffer from the cells.
The cell monolayers were quickly washed twice with ice-
cold uptake buffer without the radiolabeled substrate. Cells
were then lysed in 0.5 ml of 1% SDS/0.2 N NaOH and the
radioactivity associated with the cells was quantified. The
composition of uptake buffer in most experiments was: 25 mM
HEPES, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 5 mMf SVCT2 in mouse BMSCs, Bone and cavaria. The primers used
l and Methods. (a) Lane 1: Mouse BMSCs, Lane 2: Mouse Bone,
Upper panel shows SVCT1 and Lower panel shows SVCT2
one marrow. (c) Immunohistochemical localization of SVCT2
rmed using a polyclonal antibody specific for SVCT2. Secondary
ained with Hoechst dye.
39Expression and function of SVCT2 in bone marrow stromal cells and in osteogenesisglucose, and 140 mM NaCl. When sodium-free buffer was used,
NaCl in the uptake buffer was replaced iso-osmotically with
N-methyl-D-glucamine chloride (NMDG.Cl). When chloride-free
buffer was used, NaCl in the uptake buffer was replaced iso-
osmotically with sodium gluconate. In addition, the transport
buffer was supplemented with 1 mM dithiothreitol (DTT) toFigure 2 Ion dependency, time course and, substrate specificity
of SVCT2 in mouse BMSCs cells. (a), Uptake of [14C]-ascorbate
(20 nM) in the presence of NaCl (presence of Na+ and Cl−) or
NMDG.Cl [(N-methyl-D-glucamine chloride) absence of Na+ but
presence of Cl−] and Na gluconate (presence of Na+ and absence of
Cl−) in mice BMSCs. (b), Uptake of [14C]-ascorbate (20 nM) was
measured for different periods of time in the presence of NaCl
(presence of Na+ and Cl−) or NMDG.Cl (c), Uptake of [14C]-ascorbate
(20 nM) was measured for 15 min in the presence of NaCl with or
without various vitamins (5 mM). Uptake measured in the absence
of competing vitamins was taken as the control (100%) and uptake
measured in the presence of competing vitamins is given as a
percentage of this control value (means±SD, n=4).maintain ascorbic acid in the reduced state. Samples were
analyzed using liquid scintillation counter (Beckman Instru-
ments Inc., Fullerton, CA, USA, model LS-6500) and rate of
uptake was normalized to the protein content of each well. The
amount of protein in the cell lysatewasmeasured using the BCA
Protein Estimation Kit.
The time course of [14C] ascorbic acid (20 nM ) uptake in
Na+ -containing buffer (NaCl) and Na+-free (choline chloride)
buffer was established by conducting uptake at 2.5, 5, 15,
30, 45 and 60 min at 37 °C. Studies of concentration
dependency (range, 10 μM–1 mM) were conducted at 37 °C
using 15 min incubation representing initial uptake rates.
For analysis of substrate specificity of the transport process,
uptake of [14C] ascorbic acid was measured in the absence
and presence of various unlabeled vitamins (ascorbic acid,
thiamine, riboflavin, myoinositol, and nicotinic acid; con-
centration, 5 mM).
Differentiation of BMSCs under osteogenic conditions
BMSCs were trypsinized, harvested, washed and plated in
24-well plates at a density of 5000 cells/cm2. The cellsFigure 3 Na+-activation and Saturation kinetics of SVCT2 in
mouse BMSCs cells. (a), Uptake of [14C]-ascorbate (20 nM) was
measured for 15 min in the presence of NaCl at increasing
concentrations of Na+ (2.5–140 mM) but in the presence of a
fixed concentration of Cl− (140 mM). The concentration of Na+
was varied by replacing NaCl with NMDG.Cl iso-osmotically.
(b)Uptake of [14C]-ascorbate (20 nM) was measured for 15 min
in the presence of NaCl at increasing concentrations of
unlabeled ascorbate (2.5–250 μM). Radiolabeled ascorbate
(20 nM) was present as the tracer. Eadie-Hofstee plot
[ascorbate uptake (V) versus ascorbate uptake/ascorbate
concentration (V/S)] (means±SD, n=4).
40 S. Fulzele et al.were allowed to adhere and grow to ~90% confluence be-
fore being changed to an osteogenic medium (OM). The
OM contained DMEM supplemented with 5% FBS, 50 U/mLSVCT2
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41Expression and function of SVCT2 in bone marrow stromal cells and in osteogenesis24 h, 48 h, 4 days, 6 days, 9 days and 12 days. RNA isolation
was done at 3, 6, and 9 day time points whereas alizarin red
assaywere done at 3 days, 6 days, 9 days, 12 days, and 16 day
time points. BMSCs were also stimulated with each compo-
nent of osteogenic media separately (1 μM dexamethasone,
0.25 mM L-ascorbic acid and 10 mM β-glycerophosphate) for
24 h, and 48 h then used for measurements of ascorbic acid
uptake.Alizarin red assay
To quantify matrix calcification by the cultured BMSCs,
we used Alizarin Red S binding assay as described in the
literature (Hessle et al., 2002) with some modifications. In
brief, BMSCs (5000 cells/cm2) were plated in 24-well plates
with osteogenic media. At each time point, the medium was
removed, and washed with PBS twice. The cells were fixed
with 70% ethanol for 30 min at 4 °C. The cells were then
stained with Alizarin red solution (40 mM; 300 μl/well) for
10 min and then washed with PBS until the supernatant was
clear. The staining extent was recorded by photography and
the retained dye was then extracted with 0.25 ml of 10%
(wt./vol.) cetylpyridinium chloride solution for 10 min. The
solution was diluted at a ratio of 1:10 and read at 570 nm
with a spectrophotometer.Knockdown of SVCT2 activity using lentivirus
All work with lentiviruses was performed under BSL2
conditions. The lentiviral particles shSVCT2 (sc-41008-V),
shControl (sc-108080), Polybrene® (sc-134220) and puro-
mycin (sc-108071) was purchased from Santa Cruz Biotech-
nology, Inc. USA. In short, BMSCs were plated at 30–50%
confluence and transfected with appropriate dilutions of
lentivirus particles and polybrene. Forty-eight hours after
transfection, the cells were cultured in growth medium
containing puromycin (2 μg/ml) to obtain the stable, trans-
fected BMSC cells. The efficiency of shRNA activity was
analyzed by real-time PCR and uptake assay as describes
above. Osteogenic differentiation studies of transfected cell
were done as described above.Regulation of SVCT2 transporter by redox reaction
In order to investigate the effect of redox reaction on ascorbic
acid uptake in BMSCs, we preincubated the cells with oxidant
(Sin-1 200 μM, 400 μM and 600 μM), antioxidant (Ascorbic acid
250 μM) and a combination of oxidant and antioxidant for 18 h
and then used the cells for uptake experiments.Figure 4 a) Mouse BMSCs cultured in osteogenic medium an
(b) Quantitative analysis of the extent of mineralization in alizarin r
chloride (means±SD, n=4) (c) Real time PCR analysis of steady-stat
expression in BMSCs after treatment of osteogenic media for 3 days,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Data (m
compared to control. *Pb0.05, #Pb0.01.Statistical analysis
Data are expressed as mean±SD. Differences in measured
variables between experimental and control groups were
assessed using Student's t-test. A p-valueb0.05 was considered
statistically significant in between control and treatment
groups.
Results
Expression of vitamin C transporters in BMSCs, long
bone and calvaria
The SVCT family consists of SVCT1 and SVCT2, and both
isoforms transport ascorbic acid into cells in a Na+-coupled
manner. Therefore, it was not possible to establish the
identity of the isoform that was responsible for ascorbic acid
uptake in BMSCs by functional studies alone. Hence, prior to
performing uptake studies, we analyzed the expression of
SVCT1 mRNA and SVCT2 mRNA in mouse BMSCs, long bone,
calvaria and liver (positive control) by RT‐PCR. We used
specific primers (Kuo et al., 2004) for each isoform of the
transporter. We found no evidence of expression of SVCT1 in
BMSCs, bone, and calvaria (Fig. 1a). In contrast, SVCT2 mRNA
was detectable in BMSCs, bone, and calvaria. These results
showed that BMSCs, bone, and calvaria in mice express only
SVCT2. Liver RNA was used as a positive control for both
isoforms of the transporter.
Confocal analysis of SVCT2 protein expression
To investigate the expression and localization of SVCT2
protein in purified BMSCs (lin-negative and Sca1-positive),
slides were stained with a specific antibody against SVCT2.
The fluorescence imaging of the immuno-positive signal
indicated that SVCT2 protein was present abundantly in
BMSCs (Fig. 1b). In BMSCs, the protein was located predom-
inantly on the plasma membrane.
Functional activity of SVCT2 in BMSCs
To confirm the functional involvement of SVCT2 in BMSCs, we
carried out uptake experiments. BMSCs showed sodium-
dependent uptake of ascorbic acid (Fig. 2a). Removal of Na+
in the uptake buffer abolished the uptake almost completely,
indicating the obligatory requirement of Na+ for the uptake
process. In contrast, there was no effect of chloride on the
uptake process as the uptake rates were similar in the presence
and absence of this anion. The substrate specificity of the
transport system was investigated by assessing the ability of
various vitamins to compete with [14C]-ascorbic acid for thed stained for mineralized nodule by Alizarin red S assay.
ed S assay using elution of dye by 10% (wt./vol.) cetylpyridinium
e levels of mRNA for SVCT2, type I collagen, RUNX-2 and BMP-2
6 days and 9 days. Data for each sample were normalized with
eans±SD, n=4) are represented as the fold change in expression
Figure 5 Effects of osteogenic media, vitamin C, dexameth-
asone and b-glycerophosphate on MSCs culture for different
time point on ascorbic acid uptake. (a) BMSCs cells were
incubated with osteogenic media for 24 h, 48 h, 4 day, 6 day,
9 day, and 12 day. These cells were then used for uptake
measurements. Uptake of [14C]-ascorbic acid (20 nM) was
measured for 15 min in the presence of NaCl. (b) BMSCs cells
were incubated with vitamin C (0.25 mM), Dexamethasone
(10 nM) and b-glycerophosphate (10 mM) for different time
points. These cells were then used for uptake measurements.
Uptake of [14C]-ascorbic acid (20 nM) was measured for 15 min
in the presence of NaCl. Values (means±SD, n=4)) are
expressed relative to the control. *Pb0.05, #Pb0.01.
42 S. Fulzele et al.transport process. Unlabeled ascorbate was able to compete
with [14C]-ascorbate effectively at a concentration of 5 mM.
None of the other vitamins such as thiamine, riboflavin,Figure 6 Lentivirus-mediated SVCT2 knockdown. a) Quantitative
SVCT2 shRNA transfected and non-targeting shRNA (shNTC) mouse BM
Data (means±SD, n=3) are represented as the fold change in exp
[14C]-ascorbate (20 nM) was measured for 15 min in SVCT2 shRNA and
in control non-targeting shRNA (shNTC) was taken as the control
percentage of this control value (means±SD, n=3). c) SVCT2 knock
lentivirus containing either SVCT2 specific shRNA or non-targeting s
16 days and stained for mineralized nodule by Alizarin red S assay
real-time PCR analysis of steady-state levels of mRNA for BMP2, typ
sample were normalized with glyceraldehyde-3-phosphate dehydrog
the fold change in expression compared to control. *Pb0.05, #Pb0.myoinositol and nicotinic acid were able to compete with
[14C]-ascorbic acid, showing the specificity of this transport
system (Fig. 2c). Time-dependency of the uptakewas also done
in presence and absence of Na+. The uptake of [14C]-ascorbic
acid was linear in the Na+-containing buffer over a time period
of 30 min (Fig. 2b). In the absence of Na+, the uptake was
reduced markedly (b3% of uptake measured in the presence
of Na+). An incubation period of 15 min was selected for
subsequent uptake experiments to represent linear uptake
rates. The uptake process was found to be concentration-
dependent and saturable (Fig. 3a). The Michaelis constant
for ascorbic acid was 56±5 μM. The value for the maximal
velocity was 1.84±0.18 nmol/mg protein/15 min. Since the
transport of [14C]-ascorbate was completely Na+-dependent,
we performed Na+-activation kinetics. The uptake of
[14C]-ascorbate was measured in BMSCs in the presence of
varying concentrations of Na+ (0–140 mM). The relationship
between the uptake rate and the Na+ concentration was
sigmoidal, suggesting the involvement of more than one Na+ in
activation process (Fig. 3b). We were able to calculate the Hill
coefficient (i.e., the number of Na+ involved in the activation
process) by fitting the data to the Hill equation. The value was
2.1±0.2.Expression of SVCT2 during BMSC differentiation
into osteoblasts (osteogenesis)
BMSCs expressed SVCT2 under undifferentiated conditions.
Since these cells differentiate into osteoblasts when cul-
tured in an osteogenic medium, we wanted to determine if
the expression of the transporter is altered during differen-
tiation. BMSCs were cultured in osteogenic medium for
3–16 days and then stained Alizarin Red for quantification of
mineralization. The extent of mineralization increased in
the cultures as the time of exposure to osteogenic medium
increased (Fig. 4a and b). Real-time PCR analysis of
osteogenic markers such as BMP-2, RUNX-2 and type I
Collagen was performed on these cultures. The expression
of all these three markers was increased significantly during
differentiation of BMSCs into osteoblasts (Fig. 4c). SVCT2
expression was also upregulated significantly.
We then monitored the function of SVCT2 by measuring
ascorbic acid uptake in BMSCs during differentiation. The cells
were cultured in normal medium and in osteogenic medium
for various time periods prior to uptake measurements. The
culture of the cells in osteogenic medium increased the
uptake of ascorbic acid (Fig. 5a). The differentiation-specific
increase was maximal (50–80%) at early time points (1–6 daysreal-time PCR analysis of total SVCT2 transcripts from stable,
SCs. Data for each sample were normalized with GAPDH mRNA.
ression compared to control. *Pb0.05, # Pb0.01. b) Uptake of
non-targeting shRNA (shNTC) in mouse BMSCs. Uptake measured
(100%) and uptake measured in the SVCT2 shRNA given as a
down reduced BMSC osteogenesis. BMSCs were transduced with
hRNA (shNTC) and then subjected to osteogenic media for 8 and
, (d) quantification of Alizarin red S assay and (e) quantitative
e I collagen, RUNX-2 and osteocalcin expression. Data for each
enase (GAPDH) mRNA. Data (means±SD, n=4) are represented as
01.
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44 S. Fulzele et al.in culture); this effect decreased significantly as the culture
was continued for longer time periods. The osteogenic
medium consists of dexamethasone, ascorbic acid, and
β-glyerophosphate. To determine the identity of the chemical
in the osteogenic medium that was responsible for the
induction of SVCT2 in BMSCs, we cultured the cells for 24 h
and 48 h in the presence of dexamethasone, ascorbic acid or
β-glyerophosphate at concentrations found in the osteogenic
medium and then measured ascorbic acid uptake. The uptake
increased significantly in a time-dependent manner in
dexamethasone-treated BMSCs (Fig. 5b). Exposure to ascorbic
acid and β-glyerophosphate did not show significant change.
Knockdown of SVCT2 greatly impaired osteogenesis
of mouse BMSCs
To further investigate the role of SVCT2 in osteogenesis, a
lentivirus-based shRNA knockdown system was used. BMSCs
were transduced with lentivirus containing either SVCT2-
specific shRNA or non-target control shRNA (shNTC) and then
subjected to osteogenic induction for 8 and 16 days. The
knockdown efficiency of lentivirus shSVCT2 in BMSCs was
50-60% as assessed by real-time PCR and vitamin C uptake
assay (Fig. 6a and b). Compared to BMSCs infectedwith shNTC,
shSVCT2-expressing BMSCs showed greatly impaired osteo-
genic activity, as revealed by alizarin red staining (Fig. 6c and
d). Real time PCR showed down-regulation of bone markers
BMP2, collagen type I, RUNX2 and osteocalcin in shSVCT2-
expressing BMSCs in both, 8 and 16 days of osteogenic
induction (Fig. 6e).
Regulation of ascorbic acid uptake by redox reaction
To determine the effect of redox reaction on ascorbic acid
uptake in BMSCs, experiments were carried out in presence of
oxidant and antioxidant for 18 h. For our studies, we used an
oxidant Sin-1 which slowly decomposes to release both
superoxide and NO (Moro et al., 1998). The antioxidant
ascorbic acid was used to counter act the effect of oxidant
sin-1. We used various concentrations of Sin-1 (200 μM,
400 μM and 600 μM) and found that ascorbic acid uptake
decrease with increase in the concentration of oxidant. The
600 μM of sin-1 caused the most 40% decrease in AA uptake
where as 400 μM and 200 μM cause 30% and 20% decrease in
uptake, respectively (Fig. 7a). The antioxidant ascorbic acid
did not showed significant effect on AA uptake. When cells
were cultured in presence of both, oxidant (Sin-1 200 μM,
400 μM and 600 μM) and antioxidant (ascorbic acid 250 μM),
there was not significant different in AA uptake compare to
control (Fig. 7a). The higher concentration of Sin-1 (1000 μM)
was toxic to cells and substantially reduced cell viability but
AA protects cells from cytotoxicity of Sin-1(Fig. 7b). This
indicates that antioxidants nullify the effect of sin-1.
Altogether, these findings suggested that AA uptake activity
may be redox regulated.
Effect of aging on bone SVCT2 expression
SVCT2 expression was analyzed in femora from mice 12- and
24-months of age, along with other known bone markers. We
found that relative expression of the SVCT2 gene in bone wasmarkedly decreased with age. Compared to 12 month mice,
SVCT2 expression was down regulated two-fold in 24 month
old mice (Fig. 8). The Collagen type 1, BMP-2 and RUNX-2
were also down regulated with age (data not shown).Discussion
The expression of SVCT transporter has been studied in
osteoblast (Tsukaguchi et al., 1999), MC3T3-E1 (Fujita et al.,
2001), and articular cartilage (Clark et al., 2002; McNulty et
al., 2005) but there are no data until now on ascorbic acid
uptake or SVCT expression in BMSCs under undifferentiated
conditions as well as during osteogenic differentiation. This
report presents the first study of the characterization of
ascorbic acid uptake in BMSCs. These studies show convinc-
ingly that BMSCs exhibit robust ascorbic acid uptake activity
and that the uptake process is Na+-dependent. Our molec-
ular studies reveal that BMSCs express only SVCT2 isoform of
the Na+-coupled ascorbic acid transporter. SVCT1, another
isoform of ascorbic acid transporter that is also capable of
Na+-coupled transport, is not expressed in BMSCs. It has
been reported that osteoblasts (Tsukaguchi et al., 1999) and
MC3T3-E1 (mouse osteoblastic cell line) (Fujita et al., 2001)
express SVCT2 but not SVCT1. The characteristics of ascorbic
acid uptake in BMSCs include absolute requirement for Na+,
saturability with high affinity for its substrate, specific for
ascorbic acid, and a Na+:ascorbic acid stoichiometry of 2:1.
The Michaelis constant for the uptake process was ~56 μM.
This value is in the range of previously reported data for
SVCT2 in different cell types in different species (Rajan et
al., 1999; Liang et al., 2001; Manfredini et al., 2002; Savini
et al., 2008).
We also investigated changes in the expression of SVCT2
in BMSCs during their osteogenic differentiation. Ascorbic
acid uptake increases within 24 h after addition of the
osteogenic medium to the culture. This effect persisted for
6 days but decreased at longer periods of time. Type I
collagen expression was also upregulated in the initial phase
of osteogenesis. Similar findings have been reported for
MC3T3-El mouse calvaria-derived cell line, showing dramat-
ically increased procollagen type I mRNA within 24 h during
osteogenesis and the decreased effect at longer treatment
times (Franceschi, 1992). As expected, bone-specific markers
BMP-2 and Runx-2 were also upregulated during differentia-
tion of BMSCs into osteoblasts and this was accompanied with
increased mineralization. Wu et al. (2004) showed that
MC3T3-E1 osteoblasts SVCT2-overexpressing cells exhibited
more ability to promote mineralization and increase calcium
deposition under the stimulation of osteogenic media. Our
results match up with the Wu et al. (2004) finding that SVCT2
plays important role in osteogenesis. Our findings suggest that
SVCT2 is upregulated during the initial phase of differentiation
of BMSCs into osteoblasts, which helps to promote collagen
synthesis. This is followed by increased mineralization. There
are reports that SVCT2 expression and ascorbic acid uptake
are regulated by zinc, calcium and phosphate in murine
osteoblastic cell line MC3T3-E1 during osteogenesis (Wu et al.,
2003a,b). Analysis of the differential effects of the three
important components of the osteogenic medium reveals
that dexamethasone is primarily responsible for the observed
increase in ascorbic acid uptake. Fujita et al. (2001) also
Figure 7 Effects of Redox reaction on BMSCs ascorbic acid uptake. (a) BMSCs cells were incubated with Sin-1(200 μM, 400 μM and
600 μM) and Sin-1+ ascorbic acid (250). These cells were then used for uptake measurements. Uptake of [14C]-ascorbic acid (20 nM)
was measured for 15 min in the presence of NaCl. Values (means±SD, n=7)) are expressed relative to the control. (b) Ascorbic acid
protect cells from Sin1 induce death. BMSCs cells were incubated with no treatment, Sin-1(1000 μM) and Sin-1+ ascorbic acid
(250 μM) for 24 h. Microscopic imaging (10×) was performed using pixelink camera.
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Figure 8 Age-related declines in expression of SVCT2 at mRNA
levels in mouse bone. After reverse transcription of total RNA,
cDNA was amplified by quantitative real-time PCR. Data for
each sample were normalized with GAPDH mRNA. Data (means±
SD, n=5) are represented as the fold change in expression
compared to 12 month mouse. *Pb0.05.
45Expression and function of SVCT2 in bone marrow stromal cells and in osteogenesisreported that dexamethasone induces SVCT2 mRNA expres-
sion and uptake of AA in a mouse osteoblastic cell line
MC3T3-E1. To further clarify the role of SVCT2 in the
osteogenic differentiation of BMSCs, we knockdown SVCT2
expression utilizing lentivirus-based shRNA system and osteo-
genic analysis was performed. The knockdown of SVCT2
transporter significantly inhibits osteogenesis which clarifies
the importance of this transporter in bone formation.
We also investigated the relationship between SVCT2 and
oxidative stress in undifferentiated BMSCs. It is generally
accepted that osteoporosis and aging is associated with
oxidative stress. Oxidative stress stimulates osteoclast differ-
entiation through receptor activator of nuclear factor-kappaB
ligand (RANKL) and induces bone loss (Lee et al., 2005;
Wauquier et al., 2009). However, there are no data available
concerning the impact of oxidative stress on SVCT2 regulation
in BMSCs. In this study, we show that BMSCs cells modulated
the AA uptake according to their redox balance. The AA
uptake was down regulated in Sin-1-treated BMSCs, while
Sin-1 along with antioxidant supplementation compensates
AA uptake. Completely opposite findings were previously
46 S. Fulzele et al.reported in other cell types, where oxidative stress induced
SVCT-2 expression (Kannan et al., 2001; Savini et al., 2007;
May et al., 2010; Portugal et al., 2012) and antioxidant
supplementation reversed this effect (Savini et al., 2007). Our
study and previous studies show that antioxidant treatment
ablates the effect that oxidative stress imposes upon SVCT2
expression. The inconsistent AA uptake regulation among
these cell types may be attributable to differences in
cellularity, but it seems that AA uptake is in fact an adaptive
response to redox reaction. We also found that Sin-1
treatment (1000 μM) substantially reduced cell viability and
AA protected cells from cytotoxicity of Sin-1.
As this transporter is regulated by redox reaction, we
investigated whether there was any change in SVCT2
expression with age. Our study shows that there is an age
dependent decrease in SVCT2 transcript number in old mice
femur along with other bone marker such as Collagen type 1,
BMP-2, and RUNX2 (data not shown). Similar results were
reported in rat liver showing down regulation of SVCTwith age
(Michels et al., 2003). Liver express both sub-types, SVCT1 and
SVCT2, and only SVCT1 significantly down regulated (Michels
et al., 2003). Aging is a complicated process and is associated
with a number of systemic changes in the body. The changes in
SVCT2 expression with age in bone could be a consequence of
systemic changes such as an increasingly pro-oxidant environ-
ment, redox active metal accumulation, and change in growth
hormone and growth factors expression in aged tissues. In
aged bone, there is a decrease in osteoblast activity and an
increase in osteoclast activity. Oxidative stress increased
osteoblast apoptosis and compromises osteoblast differentia-
tion (Wauquier et al., 2009; Almeida et al., 2010). The
changes in SVCT2 expression that we observed with age
suggest that it could play an important role in bone formation.
Thus, future studies should explore the regulation of SVCT2
transporter by redox reaction and age-associated changes in
various growth factors and sex steroids.
In conclusion, the present study demonstrates for the
first time that bone and BMSCs express only the SVCT2
transporter, and this transporter plays an important role in
the osteogenic differentiation of BMSCs. Furthermore, this
transporter is regulated with age in bone, and by dexameth-
asone and redox reaction in BMSCs. There is a need to
further investigate the role of SVCT2 in bone biology to
better understand the relevance of this transporter to bone
metabolism and osteoporosis.Acknowledgments
Funding for this research was provided in part by the AO Foundation
(S-11-12F) and National Institute on Aging (P01AG036675).
References
Almeida, M., Han, L., Ambrogini, E., Bartell, S.M., Manolagas, S.C.,
2010. Oxidative stress stimulates apoptosis and activates NF-
kappaB in osteoblastic cells via a PKCbeta/p66shc signaling
cascade: counter regulation by estrogens or androgens. Mol.
Endocrinol. 24 (10), 2030–2037 (Oct).
Basu, S., Michaelsson, K., Olofsson, H., Johansson, S., Melhus, H.,
2001. Association between oxidative stress and bone mineral
density. Biochem. Biophys. Res. Commun. 288, 275–279.Bellows, C.G., Aubin, J.E., Heersche, J.N.M., Antosz, M.E., 1986.
Mineralized bone nodules formed in vitro from enzymatically
released rat calvaria cell populations. Calcif. Tissue Int. 38,
143–154.
Clark, A.G., Rohrbaugh, A.L., Otterness, I., Kraus, V.B., 2002. The
effects of ascorbic acid on cartilage metabolism in guinea pig
articular cartilage explants. Matrix Biol. 21, 175–184.
Conner, E.M., Grisham, M.B., 1996. Inflammation, free radicals, and
antioxidants. Nutrition 12, 274–277.
Franceschi, R.T., 1992. The role of ascorbic acid in mesenchymal
differentiation. (Mar) Nutr. Rev. 50 (3), 65–70 (Review).
Franceschi, R.T., Wilson, J.X., Dixon, S.J., 1995. Requirement for
Na-dependent ascorbic acid transport in osteoblast function.
Am. J. Physiol. 268, C1430–C1439.
Fujita, I., Hirano, J., Itoh, N., Nakanishi, T., Tanaka, K., 2001.
Dexamethasone induces sodium-dependant vitamin C transport-
er in a mouse osteoblastic cell line MC3T3-E1. Br. J. Nutr. 86 (2),
145–149 (Aug).
(alzararin red)Hessle, L., Johnson, K.A., Anderson, H.C., Narisawa,
S., Sali, A., Goding, J.W., Terkeltaub, R., Millan, J.L., 2002.
Tissue-nonspecific alkaline phosphatase and plasma cell mem-
brane glycoprotein-1 are central antagonistic regulators of bone
mineralization. Proc. Natl. Acad. Sci. U. S. A. 99 (14), 9445–9449
(Jul 9).
Kannan, R., Stolz, A., Ji, Q., Prasad, P.D., Ganapathy, V., 2001.
Vitamin C transport in human lens epithelial cells: evidence for
the presence of SVCT-2. Exp. Eye Res. 73, 159–165.
Kipp, D.E., McElvain, M., Kimmel, D.B., Akhter, M.P., Robinson,
R.G., Lukert, B.P., 1996. Scurvy results in decreased collagen
synthesis and bone density in the guinea pig animal model. Bone
18, 281–288.
Kuo, S.M., MacLean, M.E., McCormick, K., Wilson, J.X., 2004. Gender
and sodium-ascorbate transporter isoforms determine ascorbate
concentrations in mice. J. Nutr. 134 (9), 2216–2221 (Sep).
Lee, N.K., et al., 2005. A crucial role for reactive oxygen species in
RANKL-induced osteoclast differentiation. Blood 106 (3), 852–859.
Levine, M., Rumsey, S.C., Daruwala, R.C., Park, J.B., Wang, Y.,
1999. Criteria and recommendations for vitamin C intake. JAMA
281, 1415–1423.
Liang, W.J., Johnson, D., Jarvis, S.M., 2001. Vitamin C transport
systems of mammalian cells. (Jan-Mar) Mol. Membr. Biol. 18 (1),
87–95 (Review).
Manfredini, S., Pavan, B., Vertuani, S., Scaglianti, M., Compagnone,
D., Biondi, C., Scatturin, A., Tanganelli, S., Ferraro, L., Prasad,
P., Dalpiaz, A., 2002. Design, synthesis and activity of ascorbic
acid prodrugs of nipecotic, kynurenic and diclophenamic acids,
liable to increase neurotropic activity. J. Med. Chem. 45 (3),
559–562 (Jan 31).
May, J.M., Li, L., Qu, Z.C., 2010. Oxidized LDL up-regulates the
ascorbic acid transporter SVCT2 in endothelial cells. Mol. Cell.
Biochem. 34 (1–2), 217–222 (Oct).
McNulty, A.L., Vail, T.P., Kraus, V.B., 2005. Chondrocyte transport
and concentration of ascorbic acid is mediated by SVCT2.
Biochim. Biophys. Acta 1712 (2), 212–221 (Jun 30).
Michels, A.J., Joisher, N., Hagen, T.M., 2003. Age-related decline of
sodium-dependent ascorbic acid transport in isolated rat
hepatocytes. Arch. Biochem. Biophys. 410 (1), 112–120 (Feb 1).
Miyajima, K., Ito, R., Matsuyama, T., Togari, A., Matsumoto, S.,
Iizuka, T., 1995. Morphological differences in the skull of
ascorbic acid-deficient ODS rats. Arch. Oral Biol. 40 (4),
293–297 (Apr).
Moro, M.A., Fernández-Tomé, P., Leza, J.C., Lorenzo, P., Lizasoain,
I., 1998. Neuronal death induced by SIN-1 in the presence of
superoxide dismutase: protection by cyclic GMP. Neuropharma-
cology 37 (8), 1071–1079 (Aug).
Peterkofsky, B., 1991. Ascorbate requirement for hydroxylation and
secretion of procollagen: relationship to inhibition of collagen
synthesis in scurvy. Am. J. Clin. Nutr. 54, S1135–S1140.
47Expression and function of SVCT2 in bone marrow stromal cells and in osteogenesisPittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas,
R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S.,
Marshak, D.R., 1999. Multilineage potential of adult human
mesenchymal stem cells. Science 284 (5411), 143–147 (Apr 2).
Poal-Manresa, J., Little, K., Trueta, J., 1970. Some observations on
the effects of vitamin C deficiency on bone. Br. J. Exp. Pathol.
51, 372–378.
Portugal, C.C., da Encarnação, T.G., Socodato, R., Moreira, S.R.,
Brudzewsky, D., Ambrósio, A.F., Paes-de-Carvalho, R., 2012.
Nitric oxide modulates sodium vitamin C transporter 2 (SVCT-2)
protein expression via protein kinase G (PKG) and nuclear factor-
κB (NF-κB). J. Biol. Chem. 287 (6), 3860–3872 (Feb 3).
Prockop, D.J., 1997. Marrow stromal cells as stem cells for
nonhematopoietic tissues. Science 276, 71–74.
Rajan, D.P., Huang, W., Dutta, B., Devoe, L.D., Leibach, F.H.,
Ganapathy, V., Prasad, P.D., 1999. Human placental sodium-
dependent vitamin C transporter (SVCT2): molecular cloning
and transport function. Biochem. Biophys. Res. Commun. 262
(3), 762–768 (Sep 7).
Ruiz-Ramos, M., Vargas, L.A., Fortoul Van der Goes, T.I., Cervantes-
Sandoval, A., Mendoza-Nunez, V.M., 2010. Supplementation of
ascorbic acid and alpha-tocopherol is useful to preventing bone
loss linked to oxidative stress in elderly. J. Nutr. Health Aging 14
(6), 467–472 (Jun).
Savini, I., Rossi, A., Catani, M.V., Ceci, R., Avigliano, L., 2007.
Redox regulation of vitamin C transporter SVCT2 in C2C12
myotubes. Biochem. Biophys. Res. Commun. 361 (2), 385–390
(Sep 21).
Savini, I., Rossi, A., Pierro, C., et al., 2008. SVCT1 and SVCT2: key
proteins for vitamin C uptake. Amino Acids 34, 347–355.
Schindeler, A., Morse, A., Peacock, L., Mikulec, K., Yu, N.Y., Liu, R.,
Kijumnuayporn, S., McDonald, M.M., Baldock, P.A., Ruys, A.J.,
Little, D.G., 2010. Rapid cell culture and pre-clinical screeningof a transforming growth factor-beta (TGF-beta) inhibitor for
orthopaedics. BMC Musculoskelet. Disord. 11, 105 (May 28).
Termine, J.D., 1990. Bone matrix proteins and the mineralization
process, In: Favus, M.J. (Ed.), Primer on the Metabolic Bone
Diseases and Disorders of Mineral Metabolism, 1st ed. American
Society for Bone and Mineral Research, Kelseyville, California,
pp. 16–17.
Togari, A., Arai, M., Nakagawa, S., Banno, A., Aoki, M., Matsumoto,
S., 1995. Alteration of bone status with ascorbic acid deficiency
in ODS (osteogenic disorder Shionogi) rats. Jpn. J. Pharmacol. 68
(3), 255–261 (Jul).
Tsukaguchi, H., Tokui, T., Mackenzie, B., Berger, U.V., Chen, X.Z.,
Wang, Y., Brubaker, R.F., Hediger, M.A., 1999. A family of
mammalian Na+‐dependent L-ascorbic acid transporters. Nature
399 (6731), 70–75 (May 6).
Wauquier, F., Leotoing, L., Coxam, V., Guicheux, J., Wittrant, Y.,
2009. Oxidative stress in bone remodelling and disease. (Oct)
Trends Mol. Med. 15 (10), 468–477 (Review).
Wilson, J.X., Dixon, S.J., 1989. High-affinity sodium-dependent uptake
of ascorbic acid by rat osteoblasts. J. Membr. Biol. 111, 83–91.
Wu, X., Itoh, N., Taniguchi, T., Nakanishi, T., Tanaka, K., 2003a.
Requirement of calcium and phosphate ions in expression of
sodium-dependent vitamin C transporter 2 and osteopontin in
MC3T3-E1 osteoblastic cells. Biochim. Biophys. Acta 1641 (1),
65–70 (Jun 17).
Wu, X., Itoh, N., Taniguchi, T., Nakanishi, T., Tatsu, Y., Yumoto, N.,
Tanaka, K., 2003b. Zinc-induced sodium-dependent vitamin C
transporter 2 expression: potent roles in osteoblast differentiation.
Arch. Biochem. Biophys. 420 (1), 114–120 (Dec 1).
Wu, X., Itoh, N., Taniguchi, T., Hirano, J., Nakanishi, T., Tanaka,
K., 2004. Stimulation of differentiation in sodium-dependent
vitamin C transporter 2 overexpressing MC3T3-E1 osteoblasts.
Biochem. Biophys. Res. Commun. 317 (4), 1159–1164 (May 14).
